The Penn PET Addiction Center of Excellence (PACE) will harness the minds of radiology and psychiatry researchers to better understand opioid use disorder and develop improvement treatment options.
August 27, 2019--WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, today announces the appointment of Jon Gingrich as CEO, Echosens North America, located in Waltham, Massachusetts.
SAN FRANCISCO (August 26, 2019)—Cricket Health, a comprehensive kidney care provider with a personalized, evidence-based approach to managing care, today announced new additions to the company’s senior leadership team. Former health plan leader Colleen Reitan was appointed to the company’s board of directors and veteran health care executive Adam Hameed will be joining Cricket Health as chief development officer.
Early anticoagulation after bioprosthetic aortic valve replacement didn’t result in adverse clinical events or significantly affect aortic valve hemodynamics in a recent analysis of 4,832 heart patients, but it was linked to lower stroke rates in cases of SAVR.
A novel blood test can identify mild traumatic brain injuries (TBIs) that don’t exhibit normal concussive symptoms on CT scans, according to new research published Aug. 23 in The Lancet Neurology.
Belgium-based Miracor Medical has secured FDA breakthrough device designation for its PiCSO Impulse System, an innovation designed to treat STEMI patients.
A new type of blood test can detect mild traumatic brain injuries (TBIs) completely missed by CT scans, according to new research published in Lancet Neurology.
Urinary tract infections make up a significant portion of microbiological screening in diagnostic laboratories, yet nearly two-thirds of samples come up negative. But AI has the potential to improve the process by reducing the number of query samples and enabling diagnostic services to concentrate on those that many have actual infections.
While there is some back-and-forth debate over the true savings results from Medicare Advantage, the plans could actually cost Medicare and the American taxpayer.
